Werewolf Therapeutics, Inc. Profile Avatar - Palmy Investing

Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecule…

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of HOWL's Analysis
CIK: 1785530 CUSIP: 95075A107 ISIN: US95075A1079 LEI: - UEI: -
Secondary Listings
HOWL has no secondary listings inside our databases.